Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Clover Health Investments, Corp. - Class A Common stock (NQ:CLOV)

3.695 +0.165 (+4.67%)
Streaming Delayed Price Updated: 2:23 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments, Corp. - Class A Common stock

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Chamath Palihapitiya Launches 4 New Biotech SPACs: What Investors Should Know
One of the most famous voices in the SPAC industry is launching four new SPACs and also making several changes to his existing lineup of SPACs and former SPACs. What Happened:... 
Via Benzinga
Bill Ackman Has the Perfect Antidote to 2020’s Growth Investing Hoopla
If Ackman finds his unicorn, he’ll change the game, not only for SPACs -- but for growth investing. Here's Ackman's market antidote. 
Via InvestorPlace
Chamath Palihapitiya Calls For SPAC Regulation, What Else Did He Say?: Report
One of the most well-known names in the SPAC market is pushing for regulation in an op-ed piece published by Bloomberg Thursday. The SPAC Market: Chamath Palihapitiya called... 
Via Benzinga
Scott+Scott Attorneys at Law LLP Investigates Clover Health Investments, Corp.’s Directors and Officers for Breach of Fiduciary Duties – CLOV, IPOC
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Why Clover Health Stock Is Moving Today
Clover Health Investments Corp (NASDAQ:CLOV) shares are tr... 
Via Benzinga
Clover Health Is Only For the Most Risk-Tolerant Investors
Despite strong revenue numbers, CLOV stock is facing heavy short interest. But risk-tolerant investors may see it as a buying opportunity. 
Via InvestorPlace
EXCLUSIVE: New DeSPAC ETFs Keep It Fresh With Monthly Rebalancing, Short Selling Of SPACs
Two new SPAC ETFs launched on Wednesday that offer investors both long and short exposure to companies that have de-SPAC’d and completed mergers. The New SPACs:... 
Via Benzinga
Clover Health Investments Is a Solid Buy Contrary to All of the Bearish Calls
CLOV Stock is building its base for long term top-line growth and to cement its position as the leading Medicare insurance company. 
Via InvestorPlace
Topics Death Regulatory Compliance
Why Clover Health Stock Sank Today
Investors focused on the negatives with the company's first-quarter results more than the positives. 
Via The Motley Fool
After Checking Its Health, Things Do Not Look Good for CLOV Stock
CLOV stock went public as a play on the healthcare sector, but now its own health seems at risk amid some serious allegations. 
Via InvestorPlace
CLOV and 6 Other Reddit Stocks Drinking the Short-Squeeze Juice
7 Reddit stocks, led primarily from an abrupt short-squeeze, could lead to a brand new wave of short-squeeze madness. 
Via InvestorPlace
CLOV Stock: 5 Things to Know About Trending Reddit Favorite Clover Health Today
Shares of CLOV stock are falling on Monday despite Clover Health reporting solid earnings results for the first quarter of fiscal year 2021. 
Via InvestorPlace
What to Like (and Dislike) About Clover Health's Q1 Results
The Medicare-focused company delivered strong top-line growth but a deteriorating bottom line. 
Via The Motley Fool
Topics Lawsuit
26 Stocks Moving in Monday's Pre-Market Session
Gainers Digital Brands Group, Inc. (NASDAQ: DBGI) shares rose 73.5% to $5.90 in pre-market trading. Digital Brands, on Friday, priced its IPO at $4.15 per share. E-Home Household... 
Via Benzinga
Topics Initial Public Offering
Earnings Scheduled For May 17, 2021
Companies Reporting Before The Bell • Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter. • U.S. Well Services (NASDAQ:... 
Via Benzinga
Clover Stock Is Stuck In a Dryer Tumble of Losses and More Losses
Clover stock is stuck in a dryer tumble of losses. CLOV stock will fall without Q1 numbers on May 17 that imply full year 24% growth. 
Via InvestorPlace
Topics Initial Public Offering
Tread Carefully With Social Capital Hedosophia V Stock
As growth stocks sell off it may be best to take your time with IPOE stock, even as it approaches the closure of its merger with SoFi. 
Via InvestorPlace
Clover Health Stock Simply Has Too Much Toxic Baggage Right Now
CLOV stock has so far only benefitted its sponsor, revealing the dark side of reverse mergers. 
Via InvestorPlace
Shareholder Alert: Robbins LLP is Investigating Clover Health Investments, Corp. (CLOV) on Behalf of Shareholders
From Robbins LLP
Via Business Wire
Clover Health Faces Hurdles to Reach New Highs
CLOV stock cannot return to its early glory unless investors are convinced that its technology platform gives it a solid competitive moat. 
Via InvestorPlace
Should Investors Be Worried About Clover Health's Class Action Lawsuits?
Long-term investors should take a wait-and-see attitude. 
Via The Motley Fool
Topics Lawsuit
Tesla, Nio Significantly Cut From Baillie Gifford Portfolio, Here's What The Firm Bought Instead In Q1
Investment management firm Baillie Gifford shed significant stake in electric carmakers Tesla Inc (NASDAQ: 
Via Benzinga
Here Are The Stocks With The Highest Short Interest Rate This Week 5/6
When stocks have a high short interest rate that indicates that investors believe their share prices will decline soon. Here are the stocks on the market with the highest short... 
Via Benzinga
Clover Health Is Fraught with Mixed Signals
CLOV stock is being pushed and pulled in multiple directions. Investors won't have an easy time making a judgment right now, so hold off. 
Via InvestorPlace
Where Could Clover Health Go In The Coming Weeks?
Clover Heath Investments Corp. (NASDAQ: CLOV) shares are trading lower Wednesday morning. The share price has fallen throughout the past week, the drop is potentially due to... 
Via Benzinga
Is Clover Health a Buy Ahead of Earnings?
Clover Health reports first-quarter results on May 17. Given what we know about its 2020 results, is CLOV stock a buy ahead of earnings? 
Via InvestorPlace
Clover Health Stock Was Never a Sueeze Buy, but It’s Still Significantly Shorted
Bulls got a little too exuberant about the short-squeeze potential for CLOV stock, but there's still a possibility of further trading gains. 
Via InvestorPlace
Investors Should Avoid Opendoor Stock
Tough competition and the high valuation of Opendoor's shares are among the reasons that investors should avoid OPEN stock. 
Via InvestorPlace
These 3 IPO Stocks Are Actually Worth Buying
Don't overlook the opportunity these new publicly traded companies have to offer. 
Via The Motley Fool
Topics Initial Public Offering
Ignore the Haters, Clover Health Stock Is Building a Base for the Future
CLOV stock is extremely violent but doesn't deserve it. Management is doing well growing its reach. Eventually the model will gain more fans. 
Via InvestorPlace
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.